1. Home
  2. AMH vs KRYS Comparison

AMH vs KRYS Comparison

Compare AMH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Homes 4 Rent of Beneficial Interest

AMH

American Homes 4 Rent of Beneficial Interest

HOLD

Current Price

$33.31

Market Cap

12.0B

Sector

Real Estate

ML Signal

HOLD

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$338.60

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMH
KRYS
Founded
2012
2015
Country
United States
United States
Employees
1598
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
10.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AMH
KRYS
Price
$33.31
$338.60
Analyst Decision
Hold
Strong Buy
Analyst Count
19
11
Target Price
$34.92
$297.60
AVG Volume (30 Days)
2.1M
333.5K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
4.22%
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
$2.69
$38.74
Revenue Next Year
$2.26
$32.53
P/E Ratio
$26.59
$185.37
Revenue Growth
N/A
33.94
52 Week Low
$27.22
$130.50
52 Week High
$36.83
$382.54

Technical Indicators

Market Signals
Indicator
AMH
KRYS
Relative Strength Index (RSI) 50.40 46.70
Support Level $31.34 $246.17
Resistance Level $33.57 $382.33
Average True Range (ATR) 0.58 17.08
MACD -0.05 -5.47
Stochastic Oscillator 25.50 26.78

Price Performance

Historical Comparison
AMH
KRYS

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: